Aurinia Pharmaceuticals (AUPH) Interest & Investment Income (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Interest & Investment Income of $3.5 million for Q1 2026, little changed on a QoQ basis from $3.5 million in Q4 2025, and down 1.51% year-over-year from $3.6 million in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Interest & Investment Income (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Interest & Investment Income history runs 6 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- Quarterly Interest & Investment Income fell 1.51% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.5 million (down 15.57% YoY) and the FY2025 annual result came in at $13.6 million, down 20.02% from the prior year.
- Interest & Investment Income was $3.5 million for Q1 2026 at Aurinia Pharmaceuticals, roughly flat from $3.5 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $4.6 million in Q4 2023 and bottomed at $3.2 million in Q2 2025.
- A 4-year average of $3.9 million and a median of $4.0 million in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income declined 23.85% — and 2026, when it dropped 1.51%.
- Aurinia Pharmaceuticals' Interest & Investment Income stood at $4.6 million in 2023, then decreased by 12.7% to $4.0 million in 2024, then declined by 12.29% to $3.5 million in 2025, then increased by 0.49% to $3.5 million in 2026.
- Business Quant data shows AUPH's Interest & Investment Income at $3.5 million in Q1 2026, $3.5 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Aurinia Pharmaceuticals | 2.04 Bn | 1.66 Bn | 71.20 Mn | 3.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.52 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 3.32 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Mar 31, 2025 | 3.57 Mn |
| Dec 31, 2024 | 3.99 Mn |
| Sep 30, 2024 | 4.27 Mn |
| Jun 30, 2024 | 4.19 Mn |
| Mar 31, 2024 | 4.53 Mn |
| Dec 31, 2023 | 4.57 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Jun 30, 2021 | 142,000.00 |
| Mar 31, 2021 | 172,000.00 |
| Jun 30, 2020 | 321,000.00 |
| Mar 31, 2020 | 890,000.00 |